• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE PS FEM LT SZ 3 CEM; ATTUNE IMPLANT : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE PS FEM LT SZ 3 CEM; ATTUNE IMPLANT : KNEE FEMORAL Back to Search Results
Model Number 1504-10-103
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); No Code Available (3191)
Date of Event 11/17/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Patient received left primary attune tka to treat end-stage osteoarthritis.The patella was resurfaced, and depuy cement x 2 was utilized.The surgeon noted that the patient had posterolateral insufficiency due to an old acl injury and that the popliteus tendon was absent.The procedure was completed without complications.Patient receive a left total revision to treat pain and instability.Upon entering the joint, the surgeon confirmed gross instability of the left knee.The tibial tray and femoral component were well-fixed but revised.There was no reported product problem with the explanted tibial insert.The patella was retained.The surgeons note the patellar tendon was thinning at the tibial tubercle and was reattached with suture.The patient received competitor revision products utilizing competitor cement.The procedure was completed without complications.Doi: (b)(6) 2015.Dor: (b)(6) 2016; left knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE PS FEM LT SZ 3 CEM
Common Device Name
ATTUNE IMPLANT : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key10130017
Report Number1818910-2020-13336
Device Sequence Number2116453
Product Code JWH
UDI-Device Identifier10603295041603
UDI-Public10603295041603
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K111433
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2016
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2022
Device Model Number1504-10-103
Device Catalogue Number150410103
Device Lot Number322468
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/27/2020
Supplement Date Received by Manufacturer07/10/2020
Initial Report FDA Received Date06/08/2020
Supplement Report FDA Received Date07/13/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE MEDIAL DOME PAT 38MM; ATTUNE PS FEM LT SZ 3 CEM; ATTUNE PS FEM LT SZ 3 CEM; ATTUNE PS RP INSRT SZ 3 10MM; SMARTSET HV BONE CEMENT 40G; SMARTSET HV BONE CEMENT 40G; ATTUNE MEDIAL DOME PAT 38MM; ATTUNE PS FEM LT SZ 3 CEM; ATTUNE PS FEM LT SZ 3 CEM; ATTUNE PS RP INSRT SZ 3 10MM; SMARTSET HV BONE CEMENT 40G; SMARTSET HV BONE CEMENT 40G
Outcome Attributed to Adverse Event Required Intervention;
Patient Age60 YR
-
-